Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 20028572)

1.

UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer.

Whitson JM, Berry AB, Carroll PR, Konety BR.

Int Braz J Urol. 2009 Nov-Dec;35(6):664-70; discussion 671-2.

2.

Diagnosis and management of superficial bladder cancer.

Amling CL.

Curr Probl Cancer. 2001 Jul-Aug;25(4):219-78. Review.

PMID:
11514784
3.

[Intravesical therapy in non-muscle-invasive bladder cancer: indications and practical considerations].

Simon J, Finter F, Schnöller T, Hautmann R, Rinnab L.

Urologe A. 2009 Nov;48(11):1263-4, 1266-8, 1270-2. doi: 10.1007/s00120-009-2105-2. Review. German.

PMID:
19795104
4.

Contemporary management of superficial bladder cancer.

Pow-Sang JM, Seigne JD.

Cancer Control. 2000 Jul-Aug;7(4):335-9. Review.

PMID:
10895127
5.

Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.

Soloway MS, Jordan AM, Murphy WM.

Prog Clin Biol Res. 1989;310:215-36. Review.

PMID:
2505268
6.

Superficial bladder cancer T1G3: the choice of treatment.

Borkowski A.

BJU Int. 2002 Apr;89(6):623-7. Review. No abstract available.

PMID:
11942979
7.

[Intravesical chemotherapy of superficial bladder tumors].

Matsumura Y.

Gan To Kagaku Ryoho. 1989 Feb;16(2):193-8. Review. Japanese.

PMID:
2645832
8.

Surgical management of superficial bladder cancer (stages Ta/T1/CIS).

Smith JA Jr.

Semin Surg Oncol. 1997 Sep-Oct;13(5):328-34. Review.

PMID:
9259088
9.

An overview of intravesical therapy for superficial bladder tumors.

Herr HW, Laudone VP, Whitmore WF Jr.

J Urol. 1987 Dec;138(6):1363-8. Review. No abstract available.

PMID:
3316712
10.

When should we stop intravesical treatment in patients with superficial bladder cancer?

von Heyden B, Jakse G.

Recent Results Cancer Res. 1993;126:127-33. Review. No abstract available.

PMID:
8456183
11.

Bladder cancer: a review of non-muscle invasive disease.

Sexton WJ, Wiegand LR, Correa JJ, Politis C, Dickinson SI, Kang LC.

Cancer Control. 2010 Oct;17(4):256-68. Review.

12.

Bladder cancer detection using FISH (UroVysion assay).

Halling KC, Kipp BR.

Adv Anat Pathol. 2008 Sep;15(5):279-86. doi: 10.1097/PAP.0b013e3181832320. Review.

PMID:
18724101
13.

Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?

Ayres BE, Crew JP; Action for Bladder Cancer.

BJU Int. 2010 Feb;105 Suppl 2:14-7. doi: 10.1111/j.1464-410X.2009.09152.x. Review. No abstract available.

PMID:
20089093
14.

Current strategies in the treatment of non-muscle-invasive bladder cancer.

Oosterlinck W, Decaestecker K.

Expert Rev Anticancer Ther. 2012 Aug;12(8):1097-106. doi: 10.1586/era.12.87. Review.

PMID:
23030228
15.

Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer.

van Lingen AV, Arends TJ, Witjes JA.

Expert Rev Anticancer Ther. 2013 Nov;13(11):1257-68. doi: 10.1586/14737140.2013.852474. Review.

PMID:
24168049
16.

Intravesical therapies for bladder cancer - indications and limitations.

Logan C, Brown M, Hayne D.

BJU Int. 2012 Dec;110 Suppl 4:12-21. doi: 10.1111/j.1464-410X.2012.11619.x. Review.

PMID:
23194118
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk